REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 142 filers reported holding REPLIMUNE GROUP INC in Q2 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,419,596 | -18.7% | 2,596,119 | +10.3% | 0.00% | 0.0% |
Q2 2023 | $54,657,534 | +29.9% | 2,353,899 | -1.2% | 0.00% | 0.0% |
Q1 2023 | $42,073,025 | -31.0% | 2,382,391 | +6.2% | 0.00% | -50.0% |
Q4 2022 | $61,009,383 | +91.1% | 2,242,992 | +21.4% | 0.00% | +100.0% |
Q3 2022 | $31,919,000 | +3.8% | 1,848,167 | +5.1% | 0.00% | 0.0% |
Q2 2022 | $30,740,000 | +11.4% | 1,758,549 | +8.2% | 0.00% | 0.0% |
Q1 2022 | $27,606,000 | -34.0% | 1,625,758 | +5.3% | 0.00% | 0.0% |
Q4 2021 | $41,841,000 | -9.6% | 1,543,913 | -1.1% | 0.00% | 0.0% |
Q3 2021 | $46,262,000 | -15.5% | 1,560,769 | +9.5% | 0.00% | 0.0% |
Q2 2021 | $54,777,000 | +16.7% | 1,425,718 | -7.4% | 0.00% | 0.0% |
Q1 2021 | $46,957,000 | -12.3% | 1,539,098 | +9.6% | 0.00% | -50.0% |
Q4 2020 | $53,560,000 | +111.4% | 1,403,947 | +27.5% | 0.00% | +100.0% |
Q3 2020 | $25,340,000 | +15.1% | 1,100,749 | +24.3% | 0.00% | 0.0% |
Q2 2020 | $22,007,000 | +185.8% | 885,591 | +14.7% | 0.00% | – |
Q1 2020 | $7,700,000 | -32.9% | 772,268 | -3.5% | 0.00% | – |
Q4 2019 | $11,478,000 | +52.1% | 799,895 | +47.3% | 0.00% | – |
Q3 2019 | $7,547,000 | -4.1% | 542,948 | +1.2% | 0.00% | – |
Q2 2019 | $7,866,000 | +3.4% | 536,564 | +7.3% | 0.00% | – |
Q1 2019 | $7,610,000 | +125.1% | 500,017 | +47.9% | 0.00% | – |
Q4 2018 | $3,381,000 | -37.1% | 338,158 | +1.2% | 0.00% | – |
Q3 2018 | $5,379,000 | – | 334,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |